The research team led by Senior Researchers Yoonhee Lee from the Division of Biomedical Technology and Gyogwon Koo from the ...

The American College of Chest Physicians (CHEST) recently released a new clinical guideline on the management of patients ...

Non-small cell lung cancer (NSCLC) accounts for over 80% of lung cancer cases and is often diagnosed at advanced stages, ...

New research identifies NF-kappa-B-activating protein-like (NKAPL) as a potent tumor suppressor in non-small cell lung cancer ...

The trial will test several treatment approaches in the maintenance setting for extensive stage small cell lung cancer.

During a live event, Bruna Pellini, MD, discussed IO monotherapy as a first-line option for non–small cell lung cancer with ...

There is a great need to streamline the process from the tissue sample to the diagnostic lab, whether it's genomic or ...

Scientists have uncovered a molecular "on–off" switch that helps lung adenocarcinoma—the most common form of lung cancer—grow ...

The partners intend to develop a point-of-care testing instrument that can be used to aid the diagnosis of cancers and other diseases.

From diagnosis methods to management of comorbid infections, new lung cancer protocols adaptable for various conditions ...

Non-small cell lung cancer (NSCLC) develops in lung tissues, but when it's metastatic, it has spread to distant areas of the ...

Robert Kratzke, MD, urged insurance providers to prioritize fast biomarker testing in non–small cell lung cancer, saying it’s ...